This panel will discuss evidence of applying neuromodulation techniques in non-pain conditions. In particular, use of neuromodulation is emerging for treating some of the sequelae of the COVID-19 disease. Additionally this session will explore and discuss effects of neuromodulation on overactive bladder, heart failure as well as vascular changes in diabetes.
Upon completion of this educational activity, participants should be able to:
- Discuss how neuromodulation affects cardiac function.
- Describe how the residual COVID-19 disabling sequelae can be addressed by peripheral neuromodulation
- Discuss the efficacy of Spinal cord stimulation on the vascular changes in patients with diabetes
- Understand how peripheral nerve stimulation can have a therapeutic effect for the overactive bladder
- Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science
- Partnering with our Patients to Optimize Outcomes
- Neuromodulation and Neurosurgical Mentorship and Educational Development
- Controversies in Targeted Drug Delivery
- Spinal Cord Stimulation Mechanisms: Results from Animal Studies
Jennifer M. Hah, MD, MS
Damian S. Shin, PhD
Peter S. Staats, MD
Dalia H. Elmofty, MD
Maunak V. Rana, MD